Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-07-17

FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Viona Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for Betamethasone Dipropionate from Viona Pharmaceuticals Inc, typically reflecting labeling changes for this topica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BETAMETHASONE DIPROPIONATE (Betamethasone dipropionate)

Snippet

SUPPL AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)